http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1615666-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate | 2004-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a4770a91eaaf7ac5445c1cbc6d454b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a50f35fa7f55ed48faf4717f69a0000e |
publicationDate | 2006-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1615666-A2 |
titleOfInvention | Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent |
abstract | Combination therapy comprising the administration of an 11ß-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent useful for treating, preventing and reducing the risk of developing insulin resistance, dyslipidemia, obesity, hypertension and other related diseases and disorders. |
priorityDate | 2003-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 9922.